Learning Objectives
By the end of this session, the learner will be able to distinguish between Benzodiazepines (BZs) and Barbiturates based on their dose-response curves, mechanisms of action on the receptor, and their risk profiles for CNS depression.
1. Dose-Dependent CNS Depression
Sedative-hypnotic drugs cause a spectrum of CNS depression that increases with dosage. The critical clinical distinction lies in the shape of the dose-response curve.
| CNS State | Drug Response Profile |
|---|---|
| Benzodiazepines | Non-linear (Plateaus). CNS depression reaches a ceiling, making them safer in isolation. |
| Barbiturates / Alcohol | Linear (No Plateau). CNS depression continues to increase until medullary centers fail. |

2. Receptor Mechanisms:
vs. 
GABA is the primary inhibitory neurotransmitter. It functions by hyperpolarizing membranes through two distinct receptor types.
| Receptor | Mechanism | Result |
|---|---|---|
| Ionotropic (Directly opens channel) | ||
| Metabotropic ( |
3. Pharmacodynamics at the
Complex
Both drug classes bind to allosteric sites on the pentamer but alter chloride flow through different kinetics.
| Feature | Benzodiazepines (BZs) | Barbiturates |
|---|---|---|
| ↑ Frequency of opening | ↑ Duration of opening | |
| Mnemonic | Frenetic Benzos | Durable Barbs |
| GABA Mimetic? | No (Requires GABA to work) | Yes (Can work without GABA at high doses) |
| Other Effects | Low toxicity profile | Inhibit Complex I of the Electron Transport Chain |
4. Benzodiazepine Receptor Subtypes
The clinical effects of BZs depend on which specific receptor subtype they activate.
| Subtype | Location | Function |
|---|---|---|
| Cerebellum | Sedation (Targeted by “Z-drugs” like Zolpidem) | |
| Striatum / Spinal Cord | Anxiolysis and cognitive impairment |
Clinical Pearls:
- Hyperpolarization: By increasing
(negative ions) entering the cell, the membrane potential becomes more negative, moving away from the threshold for an action potential.
- Safety: Benzodiazepines are much harder to overdose on alone because they cannot activate the receptor without endogenous GABA (no mimetic activity).
- Antidote: Flumazenil is a competitive antagonist that reverses BZs, but it is ineffective against Barbiturates.

You must be logged in to post a comment.